中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2010年
12期
104-106
,共3页
肺源性心脏病%D-二聚体%血浆内皮素
肺源性心髒病%D-二聚體%血漿內皮素
폐원성심장병%D-이취체%혈장내피소
Chronic pulmonary Heartdisease%Plasma Endothelin(ET)%D-dimer(DD)
目的 观察抗凝治疗对慢性肺源性心脏病急性加重期D-二聚体、血浆内皮素的影响及意义.方法 慢性肺源性心脏病患者60例随机分为治疗组和对照组各30例.对照组采用常规治疗,治疗组在常规治疗的基础上加用低分子肝素(速碧林)抗凝治疗.观察两组患者住院天数及D-二聚体(DD)、血浆内皮素(ET-1)等指标治疗前后变化.结果 治疗组住院时间短,DD、ET-1下降(P＜0.05),差异有统计学意义.结论 使用低分子肝素治疗慢性肺源性心脏病可降低血液的高凝状态,提高疗效,缩短住院时间.
目的 觀察抗凝治療對慢性肺源性心髒病急性加重期D-二聚體、血漿內皮素的影響及意義.方法 慢性肺源性心髒病患者60例隨機分為治療組和對照組各30例.對照組採用常規治療,治療組在常規治療的基礎上加用低分子肝素(速碧林)抗凝治療.觀察兩組患者住院天數及D-二聚體(DD)、血漿內皮素(ET-1)等指標治療前後變化.結果 治療組住院時間短,DD、ET-1下降(P＜0.05),差異有統計學意義.結論 使用低分子肝素治療慢性肺源性心髒病可降低血液的高凝狀態,提高療效,縮短住院時間.
목적 관찰항응치료대만성폐원성심장병급성가중기D-이취체、혈장내피소적영향급의의.방법 만성폐원성심장병환자60례수궤분위치료조화대조조각30례.대조조채용상규치료,치료조재상규치료적기출상가용저분자간소(속벽림)항응치료.관찰량조환자주원천수급D-이취체(DD)、혈장내피소(ET-1)등지표치료전후변화.결과 치료조주원시간단,DD、ET-1하강(P＜0.05),차이유통계학의의.결론 사용저분자간소치료만성폐원성심장병가강저혈액적고응상태,제고료효,축단주원시간.
Objective To observe the effect of DD and ET-1 in patients with acute exacerbation of chronic pulmonary heartdisease used anticoagulant Therapy. Methods 60 patients in acute exacerbation of chronic pulmonary heartdisease who were randomly divided into treated group and control group. The control group use routine treatment, and treated group were therapied with LMWHC addedly, which based on the routed treatways. Their changes, including hospitalization days, ET-1, and DD were observed. Results Treated group' s hospital stays were shorter than control group. DD、 ET-1 were both decreased (P＜ 0. 05) in treated group have statistical significance. Conclusion Added the anticoagulant in treating chronic pulmonary heartdisease would improve the hypercoagulability and shorten hospitalization days.
